Puzzle over active surveillance for micropapillary thyroid carcinoma

Area of Science:

• Endocrinology
• Oncology
• Surgical Oncology

Background:

• Low-risk micropapillary thyroid cancer (MPTC) management involves immediate therapy or active surveillance (AS).
• Active surveillance involves monitoring for disease progression and initiating curative treatment only when necessary.

Purpose of the Study:

• To evaluate the efficacy of active surveillance as a management strategy for low-risk MPTC.
• To compare active surveillance with immediate therapy in terms of oncological outcomes and patient-reported side-effects.

Main Methods:

• Comparative analysis of patients with low-risk MPTC managed with immediate therapy versus active surveillance.
• Assessment of cancer-specific survival and disease progression rates at 10 years.

Main Results:

• Active surveillance appears to reduce overtreatment in patients with low-risk MPTC.
• Cancer-specific survival at 10 years is not compromised in patients managed with AS.
• AS allows patients to avoid side-effects associated with immediate treatment.

Conclusions:

• Active surveillance is a suitable management option for select patients with low-risk MPTC.
• Further standardization of inclusion criteria and monitoring protocols for AS is needed.